FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Cytometry A / Comparative immunophenotyping of equine multipotent mesenchy...
Cytometry. Part A : the journal of the International Society for Analytical Cytology2014; 85(8); 678-687; doi: 10.1002/cyto.a.22491

Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition.

Abstract: Horses are an approved large animal model for therapies of the musculoskeletal system. Especially for tendon disease where cell-based therapy is commonly used in equine patients, the translation of achieved results to human medicine would be a great accomplishment. Immunophenotyping of equine mesenchymal stromal cells (MSCs) remains the last obstacle to meet the criteria of the International Society for Cellular Therapy (ISCT) definition of human MSCs. Therefore, the surface antigen expression of CD 29, CD 44, CD 73, CD 90, CD 105, CD 14, CD 34, CD 45, CD 79α, and MHC II in equine MSCs from adipose tissue, bone marrow, umbilical cord blood, umbilical cord tissue, and tendon tissue was analyzed using flow cytometry. Isolated cells from the different sources and donors varied in their expression pattern of MSC-defining antigens. In particular, CD 90 and 105 showed most heterogeneity. However, cells from all samples were robustly positive for CD 29 and CD 44, while being mostly negative for CD 73 and the exclusion markers CD 14, CD 34, CD 45, CD 79α and MHC II. Furthermore, it was evident that enzymes used for cell detachment after in vitro-culture affected the detection of antigen expression. These results emphasize the need of standardization of MSC isolation, culturing, and harvesting techniques. As the equine MSCs did not meet all criteria the ISCT defined for human MSCs, further investigations for a better characterization of the cell type should be conducted.
© 2014 International Society for Advancement of Cytometry.
Get Full Text
Publication Date: 2014-06-03 PubMed ID: 24894974DOI: 10.1002/cyto.a.22491Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers in this article analyze the surface antigen expression of specific markers in different equine mesenchymal stromal cells (MSCs) to standardize their definition in line with those of human MSCs by the International Society for Cellular Therapy (ISCT). They found that the cells varied significantly in their antigen expression depending on their sources and donors, and that the use of enzymes in vitro affected antigen detection.

Objective of the Research

  • The main goal of this study is to understand and categorize the immune characteristics or immunophenotyping of equine mesenchymal stromal cells (MSCs).
  • The researchers also aimed to standardize how these cells are defined, in alignment with the criteria established by the International Society for Cellular Therapy (ISCT) for human MSCs.

Significance of the Study

  • Horses are used as a large animal model for musculoskeletal system therapies. Particularly in the case of tendon diseases, cell-based therapies have been successfully employed in equine patients.
  • Translating these results to human medicine could prove highly beneficial. To achieve this, however, a clear understanding and definition of equine MSCs is required.

Methodology and Findings

  • The expression of specific surface antigens — specifically CD 29, CD 44, CD 73, CD 90, CD 105, CD 14, CD 34, CD 45, CD 79α, and MHC II — in equine MSCs derived from adipose tissue, bone marrow, umbilical cord blood, umbilical cord tissue, and tendon tissue was examined using flow cytometry.
  • The researchers found that the isolated cells from the different sources and donors varied in their expression pattern of these MSC-defining antigens. In particular, CD 90 and 105 displayed the greatest heterogeneity.
  • Cells from all the tested samples were mostly positive for CD 29 and CD 44, while being predominantly negative for CD 73 and the exclusion markers CD 14, CD 34, CD 45, CD 79α and MHC II.
  • It was also noted that the enzymes used for cell detachment in lab conditions affected the detection of antigen expression.

Conclusion and Recommendations

  • The results highlight the need for standardization of procedures involved in the isolation, culturing, and harvesting of MSCs.
  • The equine MSCs tested did not meet all the criteria set by the ISCT for human MSCs, suggesting a need for further research to better characterize this cell type.

Cite This Article

APA
Paebst F, Piehler D, Brehm W, Heller S, Schroeck C, Tárnok A, Burk J. (2014). Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition. Cytometry A, 85(8), 678-687. https://doi.org/10.1002/cyto.a.22491

Publication

Cytometry. Part A : the journal of the International Society for Analytical Cytology
ISSN: 1552-4930
NlmUniqueID: 101235694
Country: United States
Language: English
Volume: 85
Issue: 8
Pages: 678-687

Researcher Affiliations

Paebst, Felicitas
  • Translational Centre for Regenerative Medicine (TRM), University of Leipzig, Leipzig, Germany; Faculty of Veterinary Medicine, Large Animal Clinic for Surgery, University of Leipzig, Leipzig, Germany.
Piehler, Daniel
    Brehm, Walter
      Heller, Sandra
        Schroeck, Carmen
          Tárnok, Attila
            Burk, Janina

              MeSH Terms

              • Animals
              • Antibodies / immunology
              • Antigens, Surface / metabolism
              • Biomarkers / metabolism
              • Cell Adhesion
              • Cross Reactions
              • Female
              • Flow Cytometry
              • Horses
              • Humans
              • Immunophenotyping / methods
              • Immunophenotyping / standards
              • Mesenchymal Stem Cells / cytology
              • Mesenchymal Stem Cells / immunology
              • Multipotent Stem Cells / cytology
              • Multipotent Stem Cells / immunology
              • Reference Standards

              Citations

              This article has been cited 33 times.
              1. Stage HJ, Trappe S, Söllig K, Trachsel DS, Kirsch K, Zieger C, Merle R, Aschenbach JR, Gehlen H. Multilineage Differentiation Potential of Equine Adipose-Derived Stromal/Stem Cells from Different Sources. Animals (Basel) 2023 Apr 15;13(8).
                doi: 10.3390/ani13081352pubmed: 37106915google scholar: lookup
              2. Heilen LB, Roßgardt J, Dern-Wieloch J, Vogelsberg J, Staszyk C. Isolation and cultivation as well as in situ identification of MSCs from equine dental pulp and periodontal ligament. Front Vet Sci 2023;10:1116671.
                doi: 10.3389/fvets.2023.1116671pubmed: 36968463google scholar: lookup
              3. Even KM, Gaesser AM, Ciamillo SA, Linardi RL, Ortved KF. Comparing the immunomodulatory properties of equine BM-MSCs culture expanded in autologous platelet lysate, pooled platelet lysate, equine serum and fetal bovine serum supplemented culture media. Front Vet Sci 2022;9:958724.
                doi: 10.3389/fvets.2022.958724pubmed: 36090170google scholar: lookup
              4. Trachsel DS, Stage HJ, Rausch S, Trappe S, Söllig K, Sponder G, Merle R, Aschenbach JR, Gehlen H. Comparison of Sources and Methods for the Isolation of Equine Adipose Tissue-Derived Stromal/Stem Cells and Preliminary Results on Their Reaction to Incubation with 5-Azacytidine. Animals (Basel) 2022 Aug 11;12(16).
                doi: 10.3390/ani12162049pubmed: 36009640google scholar: lookup
              5. Guest DJ, Dudhia J, Smith RKW, Roberts SJ, Conzemius M, Innes JF, Fortier LA, Meeson RL. Position Statement: Minimal Criteria for Reporting Veterinary and Animal Medicine Research for Mesenchymal Stromal/Stem Cells in Orthopedic Applications. Front Vet Sci 2022;9:817041.
                doi: 10.3389/fvets.2022.817041pubmed: 35321059google scholar: lookup
              6. Doll CU, Niebert S, Burk J. Mesenchymal Stromal Cells Adapt to Chronic Tendon Disease Environment with an Initial Reduction in Matrix Remodeling. Int J Mol Sci 2021 Nov 26;22(23).
                doi: 10.3390/ijms222312798pubmed: 34884602google scholar: lookup
              7. Peng L, Gautrot JE. Long term expansion profile of mesenchymal stromal cells at protein nanosheet-stabilised bioemulsions for next generation cell culture microcarriers. Mater Today Bio 2021 Sep;12:100159.
                doi: 10.1016/j.mtbio.2021.100159pubmed: 34841241google scholar: lookup
              8. Lara-Barba E, Araya MJ, Hill CN, Bustamante-Barrientos FA, Ortloff A, García C, Galvez-Jiron F, Pradenas C, Luque-Campos N, Maita G, Elizondo-Vega R, Djouad F, Vega-Letter AM, Luz-Crawford P. Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment. Front Immunol 2021;12:768771.
                doi: 10.3389/fimmu.2021.768771pubmed: 34790203google scholar: lookup
              9. Hagen A, Lehmann H, Aurich S, Bauer N, Melzer M, Moellerberndt J, Patané V, Schnabel CL, Burk J. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture. Front Bioeng Biotechnol 2020;8:613621.
                doi: 10.3389/fbioe.2020.613621pubmed: 33553119google scholar: lookup
              10. Haddouti EM, Randau TM, Hilgers C, Masson W, Pflugmacher R, Burger C, Gravius S, Schildberg FA. Vertebral Bone Marrow-Derived Mesenchymal Stromal Cells from Osteoporotic and Healthy Patients Possess Similar Differentiation Properties In Vitro. Int J Mol Sci 2020 Nov 5;21(21).
                doi: 10.3390/ijms21218309pubmed: 33167522google scholar: lookup
              11. Walter SG, Randau TM, Hilgers C, Haddouti EM, Masson W, Gravius S, Burger C, Wirtz DC, Schildberg FA. Molecular and Functional Phenotypes of Human Bone Marrow-Derived Mesenchymal Stromal Cells Depend on Harvesting Techniques. Int J Mol Sci 2020 Jun 19;21(12).
                doi: 10.3390/ijms21124382pubmed: 32575596google scholar: lookup
              12. Alvites RD, Branquinho MV, Caseiro AR, Amorim I, Santos Pedrosa S, Rêma A, Faria F, Porto B, Oliveira C, Teixeira P, Magalhães R, Geuna S, Varejão ASP, Maurício AC. Rat Olfactory Mucosa Mesenchymal Stem/Stromal Cells (OM-MSCs): A Characterization Study. Int J Cell Biol 2020;2020:2938258.
                doi: 10.1155/2020/2938258pubmed: 32411249google scholar: lookup
              13. Kamm JL, Parlane NA, Riley CB, Gee EK, Dittmer KE, McIlwraith CW. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression. PLoS One 2019;14(11):e0225161.
                doi: 10.1371/journal.pone.0225161pubmed: 31747418google scholar: lookup
              14. Merlo B, Teti G, Lanci A, Burk J, Mazzotti E, Falconi M, Iacono E. Comparison between adult and foetal adnexa derived equine post-natal mesenchymal stem cells. BMC Vet Res 2019 Aug 2;15(1):277.
                doi: 10.1186/s12917-019-2023-5pubmed: 31375144google scholar: lookup
              15. Gale AL, Linardi RL, McClung G, Mammone RM, Ortved KF. Comparison of the Chondrogenic Differentiation Potential of Equine Synovial Membrane-Derived and Bone Marrow-Derived Mesenchymal Stem Cells. Front Vet Sci 2019;6:178.
                doi: 10.3389/fvets.2019.00178pubmed: 31245393google scholar: lookup
              16. Pfeiffenberger M, Bartsch J, Hoff P, Ponomarev I, Barnewitz D, Thöne-Reineke C, Buttgereit F, Gaber T, Lang A. Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model. PLoS One 2019;14(4):e0214276.
                doi: 10.1371/journal.pone.0214276pubmed: 30947253google scholar: lookup
              17. Bundgaard L, Stensballe A, Elbæk KJ, Berg LC. Mapping of equine mesenchymal stromal cell surface proteomes for identification of specific markers using proteomics and gene expression analysis: an in vitro cross-sectional study. Stem Cell Res Ther 2018 Oct 25;9(1):288.
                doi: 10.1186/s13287-018-1041-8pubmed: 30359315google scholar: lookup
              18. Roth SP, Schubert S, Scheibe P, Groß C, Brehm W, Burk J. Growth Factor-Mediated Tenogenic Induction of Multipotent Mesenchymal Stromal Cells Is Altered by the Microenvironment of Tendon Matrix. Cell Transplant 2018 Oct;27(10):1434-1450.
                doi: 10.1177/0963689718792203pubmed: 30251565google scholar: lookup
              19. Ahrberg AB, Horstmeier C, Berner D, Brehm W, Gittel C, Hillmann A, Josten C, Rossi G, Schubert S, Winter K, Burk J. Effects of mesenchymal stromal cells versus serum on tendon healing in a controlled experimental trial in an equine model. BMC Musculoskelet Disord 2018 Jul 18;19(1):230.
                doi: 10.1186/s12891-018-2163-ypubmed: 30021608google scholar: lookup
              20. Barboni B, Russo V, Berardinelli P, Mauro A, Valbonetti L, Sanyal H, Canciello A, Greco L, Muttini A, Gatta V, Stuppia L, Mattioli M. Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance. Cell Transplant 2018 Jan;27(1):93-116.
                doi: 10.1177/0963689717724797pubmed: 29562773google scholar: lookup
              21. Esteves CL, Sheldrake TA, Dawson L, Menghini T, Rink BE, Amilon K, Khan N, Péault B, Donadeu FX. Equine Mesenchymal Stromal Cells Retain a Pericyte-Like Phenotype. Stem Cells Dev 2017 Jul 1;26(13):964-972.
                doi: 10.1089/scd.2017.0017pubmed: 28376684google scholar: lookup
              22. Huang Z, Godkin O, Schulze-Tanzil G. The Challenge in Using Mesenchymal Stromal Cells for Recellularization of Decellularized Cartilage. Stem Cell Rev Rep 2017 Feb;13(1):50-67.
                doi: 10.1007/s12015-016-9699-8pubmed: 27826794google scholar: lookup
              23. Burk J, Plenge A, Brehm W, Heller S, Pfeiffer B, Kasper C. Induction of Tenogenic Differentiation Mediated by Extracellular Tendon Matrix and Short-Term Cyclic Stretching. Stem Cells Int 2016;2016:7342379.
                doi: 10.1155/2016/7342379pubmed: 27630718google scholar: lookup
              24. Somal A, Bhat IA, B I, Pandey S, Panda BS, Thakur N, Sarkar M, Chandra V, Saikumar G, Sharma GT. A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells. PLoS One 2016;11(6):e0156821.
                doi: 10.1371/journal.pone.0156821pubmed: 27257959google scholar: lookup
              25. Berner D, Brehm W, Gerlach K, Gittel C, Offhaus J, Paebst F, Scharner D, Burk J. Longitudinal Cell Tracking and Simultaneous Monitoring of Tissue Regeneration after Cell Treatment of Natural Tendon Disease by Low-Field Magnetic Resonance Imaging. Stem Cells Int 2016;2016:1207190.
                doi: 10.1155/2016/1207190pubmed: 26880932google scholar: lookup
              26. Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HT, van Weeren R, Skutella T, Stadler PM. Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions--a pilot study. Stem Cell Res Ther 2016 Feb 1;7:21.
                doi: 10.1186/s13287-016-0281-8pubmed: 26830812google scholar: lookup
              27. Shikh Alsook MK, Gabriel A, Piret J, Waroux O, Tonus C, Connan D, Baise E, Antoine N. Tissues from equine cadaver ligaments up to 72 hours of post-mortem: a promising reservoir of stem cells. Stem Cell Res Ther 2015 Dec 18;6:253.
                doi: 10.1186/s13287-015-0250-7pubmed: 26684484google scholar: lookup
              28. Tessier L, Bienzle D, Williams LB, Koch TG. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells. PLoS One 2015;10(4):e0122954.
                doi: 10.1371/journal.pone.0122954pubmed: 25902064google scholar: lookup
              29. Burk J, Gittel C, Heller S, Pfeiffer B, Paebst F, Ahrberg AB, Brehm W. Gene expression of tendon markers in mesenchymal stromal cells derived from different sources. BMC Res Notes 2014 Nov 20;7:826.
                doi: 10.1186/1756-0500-7-826pubmed: 25412928google scholar: lookup
              30. Bosman LM, Ambele MA, Pepper MS. Isolation and Characterization of Equine Mesenchymal Stromal/Stem Cells. Methods Mol Biol 2025;2938:171-185.
                doi: 10.1007/978-1-0716-4607-6_19pubmed: 40445292google scholar: lookup
              31. Kim EY, Lee EJ, Kim RE, Kil TY, Kim MK. Evaluation of stability and safety of equine mesenchymal stem cells derived from amniotic fluid for clinical application. Front Vet Sci 2024;11:1330009.
                doi: 10.3389/fvets.2024.1330009pubmed: 38420210google scholar: lookup
              32. Ferreira-Baptista C, Ferreira R, Fernandes MH, Gomes PS, Colaço B. Influence of the Anatomical Site on Adipose Tissue-Derived Stromal Cells' Biological Profile and Osteogenic Potential in Companion Animals. Vet Sci 2023 Nov 24;10(12).
                doi: 10.3390/vetsci10120673pubmed: 38133224google scholar: lookup
              33. Burk J, Wittenberg-Voges L, Schubert S, Horstmeier C, Brehm W, Geburek F. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Cells 2023 Oct 24;12(21).
                doi: 10.3390/cells12212513pubmed: 37947591google scholar: lookup
              Subscribe to our newsletter
              Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.